BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, Cao F, Xing W, Si T, Yu H, Yang X, Guo Z. Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma. International Journal of Hyperthermia 2019;36:219-27. [DOI: 10.1080/02656736.2018.1556819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Dzobo K, Senthebane DA, Ganz C, Thomford NE, Wonkam A, Dandara C. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Cells 2020;9:E1896. [PMID: 32823711 DOI: 10.3390/cells9081896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
2 Qiao G, Bi K, Liu J, Cao S, Liu M, Pešić M, Lin X. Protein kinases as targets for developing anticancer agents from marine organisms. Biochim Biophys Acta Gen Subj 2021;1865:129759. [PMID: 33038451 DOI: 10.1016/j.bbagen.2020.129759] [Reference Citation Analysis]
3 Gao Y, Liu P, Shi R. Anlotinib as a molecular targeted therapy for tumors. Oncol Lett 2020;20:1001-14. [PMID: 32724339 DOI: 10.3892/ol.2020.11685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Gu CY, Wang JJ, Zhang HL, Shi GH, Ye DW. Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation. Front Oncol 2021;11:762547. [PMID: 34746004 DOI: 10.3389/fonc.2021.762547] [Reference Citation Analysis]